Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
LUNG
#4251
Pulmonx Corporation Common Stock
1.4
2
USD
-1.39%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-1.39%
Changement Mensuel
-15.98%
Evolution sur 6 mois
-10.13%
Changement Annuel
-73.70%
Clôture Précédente
1.4
4
Open
1.4
2
Bid
Ask
Low
1.4
2
High
1.4
2
Volume
23
Marchés
Actions des Marchés US
Soins de Santé
LUNG
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
35.69 M
37.02 M
37.65 M
38.54 M
39.8 M
42.24 M
—
Valuation ratios
Enterprise value
2.26 B
1.07 B
204.65 M
445.15 M
252.61 M
79.85 M
458.9 M
Price to earnings ratio
-21.81
-23.76
-4.71
-7.94
-4.72
-1.66
-9.3
Price to sales ratio
21.48
23.93
5.18
7.02
3.17
0.99
5.86
Price to cash flow ratio
-22.95
-28
-6.16
-12.82
-8.42
-2.78
-16.16
Price to book ratio
3.11
6
1.8
4.08
3.09
1.66
2.93
Enterprise value to EBITDA ratio
-73.13
-22.84
-3.23
-7.4
-4.18
-1.17
-7
Profitability ratios
Return on assets %
-0.12
-0.21
-0.3
-0.34
-0.35
-0.42
-0.38
Return on equity %
-0.14
-0.25
-0.38
-0.51
-0.66
-1
-0.83
Return on invested capital %
-591.12
-612.65
-607.46
-438.72
-314.39
-385.31
-423.44
Gross margin %
64.77
73.59
74.29
73.9
74
74.19
296.89
Operating margin %
-98.77
-97.7
-109.27
-90.19
-68.87
-59.3
-237.42
EBITDA margin %
-93.23
-93.92
-103.93
-87.17
-67.52
-57.28
-229.32
Net margin %
-98.47
-100.51
-109.8
-88.6
-67.3
-59.67
-238.74
Liquidity ratios
Quick ratio
19.1
10.92
8.35
5.77
4.88
4.28
17.35
Current ratio
19.96
11.85
9.14
6.5
5.58
5.07
20.25
Inventory turnover
1.07
0.95
0.89
1.14
1.29
1.43
1.42
Asset turnover
0.12
0.19
0.25
0.37
0.49
0.62
0.62
Solvency ratios
Debt to assets ratio
0.1
0.11
0.13
0.22
0.33
0.44
1.55
Debt to equity ratio
0.12
0.14
0.16
0.33
0.62
1.04
3.43
Long term debt to total assets ratio
0.07
0.07
0.09
0.2
0.21
0.29
1
Long term debt to total equity ratio
0.08
0.09
0.11
0.3
0.4
0.68
2.21
Per share metrics
Operating cash flow per share
-3.01
-1.15
-1.22
-0.99
-0.81
-0.8
-0.8
EBIT per share
-3.17
-1.31
-1.58
-1.63
-1.48
-1.32
-1.33
EBITDA per share
-3
-1.26
-1.5
-1.58
-1.45
-1.27
-1.28
Total debt per share
2.67
0.73
0.66
1.03
1.36
1.38
5.39
Cash per share
22.74
4.98
3.8
2.2
1.81
1.71
7.32
Net current asset value per share
24.55
5.76
4.55
3.96
3.48
2.5
11.29
Tangible book value per share
21.93
5.28
4.08
3.05
2.13
1.27
6.22
Working capital per share
23.32
5.27
4.06
3.35
2.86
2.01
9.06
Book value per share
22.2
5.35
4.15
3.12
2.19
1.33
6.45
Nouvelles
TruBridge (TBRG) Beats Q4 Earnings Estimates
Pulmonx Corporation (LUNG) Q4 2025 Earnings Call Transcript
Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates
Le BPA de Pulmonx a dépassé les attentes de 0,14$, le CA en dessous des prévisions
Pulmonx earnings beat by $0.14, revenue fell short of estimates
Pulmonx finalise une facilité de crédit de 60 millions de dollars avec Perceptive Advisors
Pulmonx finalise une facilité de crédit de 60 millions $ avec Perceptive
Pulmonx closes $60 million credit facility with Perceptive
Pulmonx closes $60M credit facility with Perceptive Advisors
Broadcom, Veeva Systems, Okta and more set to report earnings Wednesday
Fulgent Genetics, Inc. (FLGT) Q4 Earnings Top Estimates
Privia Health (PRVA) Q4 Earnings and Revenues Beat Estimates